Ro 24-7429
Modify Date: 2024-01-13 01:20:20
Ro 24-7429 structure
|
Common Name | Ro 24-7429 | ||
|---|---|---|---|---|
| CAS Number | 139339-45-0 | Molecular Weight | 272.73300 | |
| Density | 1.36g/cm3 | Boiling Point | 514.6°C(760mmHg),计算值 | |
| Molecular Formula | C14H13ClN4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 265°C | |
Use of Ro 24-7429Ro24-7429 is a potent and orally active HIV-1 transactivator protein Tat antagonist. Ro24-7429 is also a runt-related transcription factor 1 (RUNX1) inhibitor. Ro24-7429 has anti-HIV, antifibrotic and anti-inflammatory effects[1][2]. |
| Name | 7-Chloro-N-Methyl-5-(1H-Pyrrol-2-Yl)-3H-1,4-Benzodiazepin-2-Amine |
|---|---|
| Synonym | More Synonyms |
| Description | Ro24-7429 is a potent and orally active HIV-1 transactivator protein Tat antagonist. Ro24-7429 is also a runt-related transcription factor 1 (RUNX1) inhibitor. Ro24-7429 has anti-HIV, antifibrotic and anti-inflammatory effects[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Ro 24-7429 (0.1-5 μM; 3 days) induces apoptosis of cultured PBMCs in a dose-dependent manner[1]. Ro 24-7429 (1-25 μM) also induces apoptosis and inhibits antigen-induced lymphocyte proliferation[1]. Ro24-7429 (50-200 μM; 24-72 hours) strongly inhibits the proliferation of A549 and HLF cells in a dose-dependent manner. Ro24-7429 treatment (75 μM) significantly reduces TNF-α-induced up-regulation of RUNX1 mRNA by 50% at 48 hours[2]. Apoptosis Analysis[1] Cell Line: Peripheral blood mononuclear cells (PBMCs) Concentration: 0.1 μM, 1 μM, 5 μM Incubation Time: 3 days Result: Induced a dose-dependent increase in apoptosis of cultured PBMCs. |
| In Vivo | Ro24-7429 (17.5-70 mg/kg; i.p.; daily; for 14 or 21 days) treatment robustly ameliorates lung fibrosis and inflammation in the Bleomycin-induced pulmonary fibrosis (PF) mouse model. Ro24-7429 curbs expression of fibrosis markers in injured mouse lungs[2]. Animal Model: C57BL/6J male and female mice (aged 6 to 8 weeks) induced by Bleomycin[2] Dosage: 17.5 mg/kg, 35 mg/kg, and 70 mg/kg Administration: i.p.; daily; for 14 or 21 days Result: Ameliorated lung fibrosis and inflammation in the Bleomycin-induced PF mouse model. |
| References |
| Density | 1.36g/cm3 |
|---|---|
| Boiling Point | 514.6°C(760mmHg),计算值 |
| Molecular Formula | C14H13ClN4 |
| Molecular Weight | 272.73300 |
| Flash Point | 265°C |
| Exact Mass | 272.08300 |
| PSA | 52.54000 |
| LogP | 2.03060 |
| Ro 24-7429 |
| Aids003055 |
| [7-Chloro-5-(1H-Pyrrol-2-Yl)-3H-1,4-Benzodiazepin-2-Yl]-Methyl-Amine |
| Aids-003055 |